Sorafenib

inquiry

Cat No.

CEI-1111

Description

Sorafenib (marketed as Nexavar by Bayer) is a multikinase inhibitor targeting a number of serine/threonine and receptor tyrosine kinases. It is a drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma) and advanced primar.

Abbr

Sorafenib(ZHX2, KDR)

Alias

AFR1, RAF

Product Overview

multikinase inhibitor targeting a number of serine/threonine and receptor tyrosine kinases

CAS_No

284461-73-0

Molecular Weight

464.82

Purity

> 95%

Stability

2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO

Storage

4 centigrade

Synonyms

AFR1, RAF

Targets

Raf, VEGFR

Molecular Formula

C21H16ClF3N4O3

Chemical Name

4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide

Solubility

DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL

Name:

Email *

Phone:*

Company/Institution:

Country or Region:

Quantity:

Services & Products Interested *

Project Description:

Our Products Cannot Be Used As Medicines Directly For Personal Use.

Products

Online Inquiry